CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agarwal, A.
Right arrow Articles by Singh, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agarwal, A.
Right arrow Articles by Singh, U.
Canadian Journal of Anesthesia 50:297-300 (2003)
© Canadian Anesthesiologists' Society, 2003

Cardiothoracic Anesthesia, Respiration and Airway

Salbutamol, beclomethasone or sodium chromoglycate suppress coughing induced by iv fentanyl

[Le salbutamol, la béclométhasone ou le chromoglycate de sodium suppriment la toux causée par le fentanyl iv]

Anil Agarwal, MD*, Afzal Azim, MD*, Sushil Ambesh, MD*, Neeta Bose, MD*, Sanjay Dhiraj, MD*, Dinesh Sahu, MD* and Uttam Singh, PhD{dagger}

* From the Department of Anesthesia and
{dagger} Biostatistics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.

Address correspondence to: Dr Anil Agarwal, Type IV/48, SGPGIMS, Lucknow 226 014, India. Fax: +91 522 2668017, 2668047, 2668078; E-mail: aagarwal{at}sgpgi.ac.in


    Abstract
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
Purpose: Fentanyl, a synthetic opioid, is a popular choice amongst anesthesiologists in the operating room. Preinduction iv fentanyl bolus is associated with coughing in 28–45% of patients. Coughing due to fentanyl is not always benign and at times may be explosive requiring immediate intervention. We have studied the role of aerosol inhalation of salbutamol, beclomethasone and sodium chromoglycate in preventing fentanyl induced coughing and have compared their efficacy.

Methods: Two hundred patients aged 18–60 yr, undergoing elective laparoscopic cholecystectomy were randomized into four groups of 50 each. Group I served as control, while Groups II, III and IV received an aerosol inhalation of salbutamol, beclomethasone or sodium chromoglycate 15 min prior to entering the operating room. Following iv fentanyl (2 µg•kg-1) the incidence of cough was recorded and graded as mild (1–2), moderate (3–5) and severe (> 5) depending on the number of coughs observed. Results were analyzed using ‘z’ and Fischer’s Exact test. A P value of <= 0.05 was considered significant.

Results: The incidence of cough was 28% in the control group, 6%, 0% and 4% in the salbutamol, beclomethasone and sodium chromoglycate groups respectively. Occurrence of cough was significantly low (P <= 0.05) in the treatment groups, however the difference amongst the groups was not significant (P >= 0.05).

Conclusion: The use of salbutamol, beclomethasone or sodium chromoglycate aerosol 15 min prior to iv fentanyl administration minimizes fentanyl-induced coughing.


    Introduction
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
OPIOIDS have been administered for hundreds of years to allay anxiety and decrease pain associated with surgery. They are used as premedicants and analgesics perioperatively.1 Fentanyl, a synthetic opioid, is a popular choice amongst anesthesiologists because of its quick onset, short duration of action, easy titrability, intense analgesia, cardiovascular stability and low histamine release.2,3 A preinduction bolus of fentanyl is associated with coughing in 28–45% patients but this has not been considered a serious anesthetic complication.4,5 Coughing due to fentanyl may not always be benign and brief, and at times, coughing can be explosive requiring immediate intervention on the operating table.6 Further, coughing is known to be associated with increased intracranial, intra-occular and intra-abdominal pressures.

The various mechanisms proposed to explain fentanyl-induced cough are: inhibition of central sympathetic outflow leading to vagal predominance,7 histamine release, deformation of the tracheobronchial wall stimulating the irritant receptors leading to reflex bronchoconstriction and cough.8,9 Salbutamol, beclomethasone and sodium chromoglycate are used routinely in the management of bronchospasm. Therefore, we postulated that aerosol inhalation of these drugs would prevent fentanyl-induced cough.


    Material and methods
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
Following approval from Institutional Research and Ethical Committees, informed consent was obtained from all patients included in this randomized, prospective and controlled study.

Two hundred ASA I and II patients of either sex, aged between 18–60 yr, scheduled for elective laparoscopic cholecystectomy under general anesthesia were randomly assigned into four groups of 50 each using a computer generated table of random numbers. Group I served as control and did not receive any treatment while patients belonging to Groups II, III and IV inhaled one metered aerosol puff of salbutamol, beclomethasone or sodium chromoglycate 15 min prior to entering the operating room. Patients having a history of chronic obstructive airway disease, an upper respiratory infection in the last two weeks, chronic smoking or recent intake of angiotensin converting enzyme inhibitors, bronchodilators or steroids were excluded from the study.

In the operating room venous access was established. Monitoring consisted of electrocardiogram, non-invasive blood pressure, oxygen saturation and capnography. A fentanyl bolus of 2 µg•kg-1 was given iv over a period of five seconds following which the incidence of cough, if any, was recorded by another anesthesiologist who was blinded to drug therapy. Depending upon the number of coughs observed it was graded as mild (1–2), moderate (3–5) and severe (> 5). Induction of anesthesia was commenced once cough subsided.

Considering the expected incidence of cough following iv fentanyl to be 35% and assuming a reduction up to 10% following any of the treatments and a power of 80%, the minimum sample size required in each group was 43. Anticipating some variability in reduction we included 50 patients in each group. Patients’ characteristics were compared by unpaired Student’s t test. Comparisons between groups were performed for overall incidence of coughing by ‘z’ test. Coughing was further compared separately at various levels of severity by Fischer’s Exact test. A P < 0.05 was considered significant.


    Results
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
The demographic data were comparable in the four groups (Table IGo). Fourteen (28%) patients had cough in the control group (Group I). Three (6%) patients had cough in the salbutamol group (II) and two (4%) patients had cough in the sodium chromoglycate group (IV). None of the patients in the beclomethasone group (III) had any cough. Severe cough was not observed in any of the treatment groups. The total incidence of cough was significantly higher (P <= 0.05) in the control group when compared to any of the treatment groups (Table IIGo). However, no significant difference in the incidence of cough was observed in the three treatment groups.


View this table:
[in this window]
[in a new window]
 
TABLE I Patient characteristics
 

View this table:
[in this window]
[in a new window]
 
TABLE II Severity of cough following a 2 µg•kg-1 bolus of fentanyl
 

    Discussion
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
All bronchodilators, when given as an aerosol, result in a rapid onset of action and deposition of more then 10% of the drug in the lungs leading to effective bronchodilatation.10 We observed that a metered dose of salbutamol (B2 adrenergic agonist), beclomethasone (corticosteroid) and sodium chromoglycate (mast call stabilizer) significantly reduced the incidence of cough evoked by iv bolus of 2 µg•kg-1 fentanyl.

In our study, fentanyl (2 µg•kg-1) induced cough in 28% of control patients. Bohrer et al., in a study of 150 patients undergoing coronary artery bypass grafting, observed a 45% incidence of cough when fentanyl (7 µg•kg-1) was administered via a central venous catheter.5 The higher incidence could be due to the larger dose and the central route used by Bohrer et al. Lui et al. reported a 46% incidence of fentanyl-induced cough using a dose of 5 µg•kg-1.11 In another study, Phua et al. observed a 28% incidence of cough following 1.5 µg•kg-1 iv fentanyl injected through a peripheral venous cannula.6 The latter observations are similar to our finding.

Various mechanisms have been proposed to explain fentanyl-induced cough. Fentanyl has been shown to inhibit central sympathetic outflow causing activation of the vagus nerve, inducing cough and reflex bronchoconstriction.7 Lui et al. hypothesized that fentanyl-induced cough is due to bronchoconstriction.11 They evaluated the effects of nebulized terbutaline (B2 agonist) and concluded that terbutaline inhalation effectively suppressed the cough response from 43% to 3%. Salbutamol inhalation causes bronchodilation and is also an effective antitussive agent both in normal and asthmatic patients. Inhalation of a metered dose of salbutamol significantly decreased the incidence of cough in our study.

In humans, fentanyl constricts the tracheal smooth muscle and hence the irritant receptors nearby may be stimulated following deformation of the tracheobronchial wall.9 These receptors, when stimulated, can trigger the cough reflex via the vagal afferent pathway. We used corticosteroid (beclomethasone) inhalation therapy as it is known to reduce bronchial hyperirritability, mucosal edema and also to suppress the inflammatory response to trigger stimuli.12 None of the patients who received beclomethasone inhalation had any cough following a preinduction bolus of iv fentanyl.

Histamine release in humans from lung mast cells is a possible mechanism of fentanyl-induced cough, though this appears very unlikely as fentanyl rarely causes histamine release.13 Sodium chromoglycate inhibits degranulation of mast cells triggered by various stimuli. The release of histamine, leukotrienes, interleukins and other inflammatory mediators from mast cells may be responsible for coughing. Metered dose inhalation of sodium chromoglycate significantly decreased the incidence of cough in our study.

We conclude that pretreatment with salbutamol, beclomethasone or sodium chromoglycate aerosol prior to a 2 µg•kg-1 iv fentanyl bolus reduces the incidence of cough. Therefore, we recommend that all patients likely to experience adverse events associated with fentanyl-induced cough should receive a metered dose of one of these drugs by inhalation 15 min prior to induction of anesthesia.

Revision received November 29, 2002. Accepted for publication September 16, 2002.


    References
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
1 Bailey PL, Egan TD, Stanley TH. Intravenous opioid anesthetics. In: Miller RD (Ed.). Anesthesia, 5th ed. New York: Churchill Livingstone Inc.; 2000: 273–376.

2 Grell FL, Koons RA, Denson JS. Fentanyl in anesthesia: a report of 500 cases. Anesth Analg 1970; 49: 523–32.[Free Full Text]

3 Bovill JG, Sebel PS, Stanley TH. Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia. Anesthesiology 1984; 61: 731–55.[Medline]

4 Tweed WA, Dakin D. Explosive coughing after bolus fentanyl injection. Anesth Analg 2001; 92: 1442–3.[Free Full Text]

5 Bohrer H, Fleischer F, Werning P. Tussive effect of a fentanyl bolus administered through a central venous catheter. Anaesthesia 1990; 45: 18–21.[Medline]

6 Phua WT, Teh BT, Jong W, Lee TL, Tweed WA. Tussive effect of a fentanyl bolus. Can J Anaesth 1991; 38: 330–4.[Abstract/Free Full Text]

7 Reitan JA, Stengert KB, Wymore ML, Martucci RW. Central vagal control of fentanyl-induced bradycardia during halothane anesthesia. Anesth Analg 1978; 57: 31–6.[Abstract/Free Full Text]

8 Stellato C, Cirillo R, de Paulis A, et al. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology 1992; 77: 932–40.[Medline]

9 Yasuda I, Hirano T, Yusa T, Satoh M. Tracheal constriction by morphine and by fentanyl in man. Anesthesiology 1978; 49: 117–9.[Medline]

10 Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981; 36: 52–5.[Abstract/Free Full Text]

11 Lui PW, Hsing CH, Chu YC. Terbutaline inhalation suppresses fentanyl-induced coughing. Can J Anaesth 1996; 43: 1216–9.[Abstract/Free Full Text]

12 Fanta CH, Rossing TH, McFadden ER Jr. Glucocorticoids in acute asthma. A critical controlled trial. Am J Med 1983; 74: 845–51.[Medline]

13 Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987; 66: 723–30.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
T. Oshima, Y. Kasuya, Y. Okumura, T. Murakami, and S. Dohi
Identification of independent risk factors for fentanyl-induced cough: [L'identification de facteurs de risque independants pour la toux induite par le fentanyl].
Can J Anesth, August 1, 2006; 53(8): 753 - 758.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J.-A. Lin, C.-C. Yeh, M.-S. Lee, C.-T. Wu, S.-L. Lin, and C.-S. Wong
Prolonged Injection Time and Light Smoking Decrease the Incidence of Fentanyl-Induced Cough
Anesth. Analg., September 1, 2005; 101(3): 670 - 674.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
C. K. Pandey, M. Raza, R. Ranjan, V. Singhal, M. Kumar, A. Lakra, D. V. Navkar, A. Agarwal, R. B. Singh, U. Singh, et al.
Intravenous lidocaine 0.5 mg{middle dot}kg-1 effectively suppresses fentanyl-induced cough: [L'administration iv de 0,5 mg{middle dot}kg-1 de lidocaine supprime efficacement la toux induite par le fentanyl]
Can J Anesth, February 1, 2005; 52(2): 172 - 175.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C. K. Pandey, M. Raza, R. Ranjan, A. Lakra, A. Agarwal, U. Singh, R. B. Singh, and P. K. Singh
Intravenous Lidocaine Suppresses Fentanyl-Induced Coughing: A Double-Blind, Prospective, Randomized Placebo-Controlled Study
Anesth. Analg., December 1, 2004; 99(6): 1696 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
C.-S. Lin, W.-Z. Sun, W.-H. Chan, C.-J. Lin, H.-M. Yeh, and M. S. Mok
Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough: [L'administration iv de lidocaine et d'ephedrine, mais non de propofol, supprime la toux causee par le fentanyl]
Can J Anesth, August 1, 2004; 51(7): 654 - 659.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agarwal, A.
Right arrow Articles by Singh, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agarwal, A.
Right arrow Articles by Singh, U.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS